세계의 소수성 상호작용 크로마토그래피 시장 : 제품 및 서비스별, 샘플 유형별, 용도별, 최종 사용자별 - 기회 분석과 산업 예측(2024-2033년)

Hydrophobic Interaction Chromatography Market By Product and Service, By Sample type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,228,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,432,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

소수성 상호작용 크로마토그래피 시장

세계의 소수성 상호작용 크로마토그래피 시장은 2023년 4억 6,189만 달러, 2033년 9억 5,293만 달러에 이를 것으로 추정되며, 2024년부터 2033년까지 CAGR은 7.5%로 예상됩니다.

소수성 상호작용 크로마토그래피(HIC)는 단백질 및 기타 생체분자를 소수성으로 구별하는 생체분자 분리 기술입니다. HIC의 작동 원리는 이동상의 이온 강도의 영향 하에서 단백질이 거치형상의 소수성기에 가역적으로 결합하는 것입니다. 이 기술은 항체 분리, 단백질 정제, 생명 공학 및 제약 산업에서 소수성 화합물의 분리에 적용됩니다.

소수성 상호작용 크로마토그래피 시장은 의약품과 백신의 개발 과정에서 HIC가 이용되고 있기 때문에 세계 바이오 의약품 산업이 확대되고 있는 것이 주요 요인이 되고 있습니다. 또한 정부와 민간단체에 의한 바이오테크놀러지 연구분야에 대한 투자 증가가 시장의 성장을 뒷받침하고 있습니다. 소수성 상호작용 크로마토그래피 시장의 주목할만한 동향은 식품 및 영양 보조 식품 산업에서 HIC의 이용입니다. 단백질과 펩티드의 분리 및 정제에 의해 맛과 영양가를 개선하기 위해 HIC가 이용되고 있습니다.

그러나 이 기술은 확장할 수 없으며 광범위한 정화 요건을 충족할 수 없는 것이 시장 개척의 방해가 되었습니다. 또한, HIC는 상대적으로 시간이 많이 걸리는 기술이며, 친화도 및 이온 교환 크로마토그래피와 같은 대체 기술과의 엄격한 경쟁에 직면하고 있습니다. 이것은 HIC의 유용성을 낮추고 시장 성장을 크게 억제합니다. 한편, 바이오벤처 기업 증가와 투자에 대한 급증은 소수성 상호작용 크로마토그래피 시장에 유리한 성장 기회를 가져올 것으로 예상됩니다. McKinsey의 데이터에 따르면 벤처 캐피탈의 바이오 신흥 기업 투자는 2016년 2200개에서 2021년 3100개로 증가했습니다. 게다가 신흥기업이 2021년에 세계에서 모은 자금은 340억 달러를 넘어 2020년 총 160억 달러의 2배 이상입니다. 이러한 투자가 급증함에 따라 단백질 및 분자 생물학 관련 연구가 증가하고 첨단 HIC 장치에 대한 수요가 높아질 것으로 예상됩니다.

부문 검토

소수성 상호작용 크로마토그래피 시장은 제품 및 서비스, 샘플 유형, 용도, 최종 사용자, 지역으로 구분됩니다. 제품 및 서비스별로 시장은 제품과 서비스로 이분됩니다. 제품 부문은 수지, 완충액, 컬럼 등으로 분류됩니다. 수지 부문은 비드와 그 밖으로 이분됩니다. 컬럼 부문은 또한 프리팩드 컬럼과 빈 컬럼으로 구분됩니다. 프리팩드 컬럼 부문은 또한 일회용 및 재사용 가능으로 분류됩니다. 시료 유형에 따라 시장은 단클론 항체, 백신, 세포 배양 시료, 혈장 및 혈청 시료 등으로 분류됩니다. 용도별로는 단백질 및 항체 정제, 백신 개발, 창약, 식품 및 영양 보조 식품 개발로 분류됩니다. 단백질 및 항체 정제 분야는 수지에 따라 비드와 기타로 분류됩니다. 최종 사용자별로는 제약 및 바이오의약품기업, 수탁연구기관 및 수탁제조기관, 연구 및 학술기관 등으로 분류됩니다. 지역별로는 시장은 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽), 아시아태평양(일본, 중국, 인도, 호주, 한국, 기타 아시아태평양), 라틴아메리카, 중동 및 아프리카(브라질, 남아프리카, 사우디아라비아, 기타 라틴아메리카와 중동 및 아프리카)로 분류됩니다.

주요 조사 결과

제품 및 서비스별로는 제품 부문이 2023년 시장 점유율을 독점했습니다.

샘플 유형별로는 단클론항체 분야가 높은 점유율을 차지했습니다.

용도별로는 단백질 및 항체 정제 분야가 2023년에 가장 높은 시장 점유율을 차지했습니다.

최종 사용자별로는 제약 및 바이오 제약 기업이 2023년에 가장 높은 점유율을 차지했습니다.

지역별로는 북미가 2023년에 가장 높은 수익을 올렸습니다.

이해관계자를 위한 주요 이점

이 보고서는 2023년부터 2033년까지 소수성 상호작용 크로마토그래피 시장 분석 시장 부문, 현재 동향, 추정 및 동향 분석을 정량적으로 제공하여 우세한 소수성 상호작용 크로마토그래피 시장 기회를 확인합니다.

시장 성장 촉진요인, 시장 성장 억제요인, 시장 기회와 관련된 정보와 함께 시장 조사를 제공합니다.

Porter's Five Forces 분석은 이해관계자들이 이익에 중점을 둔 비즈니스 결정을 내리고 공급업체와 구매자의 네트워크를 강화할 수 있도록 구매자와 공급업체의 잠재력을 보여줍니다.

소수성 상호작용 크로마토그래피 시장의 세분화를 상세하게 분석함으로써 시장 기회를 파악할 수 있습니다.

각 지역의 주요 국가는 세계 시장에 대한 수익 공헌도에 따라 매핑됩니다.

시장 기업 포지셔닝은 벤치마킹을 용이하게 하고 시장 기업의 현재 위치를 명확하게 이해할 수 있습니다.

지역별 및 세계 소수성 상호작용 크로마토그래피 시장 동향, 주요 기업, 시장 부문, 응용 분야, 시장 성장 전략의 분석을 포함합니다.

이 보고서에서 가능한 보고서 사용자 정의(추가 비용 및 일정이 있습니다.)

• 국가, 지역, 세계 수준의 환자/역학 데이터
• 규제 가이드라인
• 고객의 관심에 따른 추가 기업 프로파일
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 예측
• 기업 프로파일의 확장 목록
• 과거 시장 데이터
• SWOT 분석

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
    • 바이오의약품의 연구개발비 증가
    • 생물제제와 단클론항체(mAbs) 수요 증가
    • 바이오시밀러의 채용 증가
  • 억제요인
    • 숙련된 노동력 부족
    • 높은 초기 투자 및 운영 비용
  • 기회
    • 신흥 시장에서의 성장 기회
    • 소수성 상호작용 크로마토그래피(HIC)의 기술적 진보

제4장 소수성 상호작용 크로마토그래피 시장 : 제품 및 서비스별

• 개요
• 제품
  • 제품 유형별 소수성 상호작용 크로마토그래피 시장
    • 수지 소수성 상호작용 크로마토그래피 시장 : 유형별
    • 컬럼 소수성 상호작용 크로마토그래피 시장 : 유형별
    • 충전된 컬럼 소수성 상호작용 크로마토그래피 시장 : 유형별
• 서비스

제5장 소수성 상호작용 크로마토그래피 시장 : 샘플 유형별

• 개요
• 단클론항체
• 백신
• 세포 배양 샘플
• 혈장 및 혈청 샘플
• 기타

제6장 소수성 상호작용 크로마토그래피 시장 : 용도별

• 개요
• 단백질 및 항체 정제
  • 단백질 및 항체 정제의 소수성 상호작용 크로마토그래피 시장 : 수지별
• 백신 개발
• 창약
• 식품 및 영양 보조 식품 개발

제7장 소수성 상호작용 크로마토그래피 시장 : 최종 사용자별

• 개요
• 제약 및 바이오 의약품 기업
• 수탁연구기관 및 수탁제조기관
• 연구 및 학술기관
• 기타

제8장 소수성 상호작용 크로마토그래피 시장 :지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카, 중동 및 아프리카
  • 브라질
  • 남아프리카
  • 사우디아라비아
  • 기타

제9장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2023년

제10장 기업 프로파일

• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Thermo Fisher Scientific Inc.
• Tosoh Corporation
• Geno Technology, Inc.
• Danaher Corporation
• Sepax Technologies, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Waters Corporation
• KNAUER Wissenschaftliche Gerate GmbH

JHS

영문 목차

영문목차

Hydrophobic Interaction Chromatography Market

The hydrophobic interaction chromatography market was valued at $461.89 million in 2023 and is estimated to reach $952.93 million by 2033, exhibiting a CAGR of 7.5% from 2024 to 2033.

Hydrophobic interaction chromatography (HIC) is a biomolecular separation technique that differentiates proteins and other biomolecules depending on their hydrophobicity. The working principle of HIC involves the reversible binding of proteins to hydrophobic groups on a stationary phase, under the influence of ionic strength of a mobile phase. The technique finds application in antibody isolation, protein purification, and separation of hydrophobic compounds in biotechnological & pharmaceutical industries.

The expanding biopharmaceutical industry across the globe is a key driver of the hydrophobic interaction chromatography market as it utilizes HIC in the development process of medicines and vaccines. In addition, rise in investments in the biotechnology & research sector by governments and private organizations has propelled the growth of the market. A notable trend acquiring traction in the hydrophobic interaction chromatography market is the use of HIC in the food and dietary supplement industries. They utilize HIC to improve taste and nutritional value by the separation & purification of proteins and peptides.

However, the inability of the technique scale-up and cater to extensive purification requirements hampers the development of the market. Furthermore, HIC is a relatively time-consuming technique and faces stringent competition from alternatives such as affinity & ion-exchange chromatography. This reduces the utility of HIC and restrains the market growth significantly. On the contrary, increase in the number of biotech start-ups and surge in investments in them is expected to present lucrative growth opportunities for the hydrophobic interaction chromatography market. McKinsey data states that investments by venture capital firms increased from 2,200 biotech start-ups globally in 2,016 to 3,100 in 2021. Moreover, the start-ups collected more than $34 billion globally in 2021, which was more than double the 2020 total of $16 billion. This upsurge in investments is anticipated to increase protein- and molecular biology-related research, fueling the requirement for advanced HIC equipment.

Segment Review

The hydrophobic interaction chromatography market is segmented into product & service, sample type, application, end user, and region. By product & service, the market is bifurcated into product and service. The product segment is further categorized into resin, buffer, column, and others. The resin segment is further bifurcated into beads and others. The column segment is further divided into pre-packed columns and empty columns. The pre-packed column segment is further categorized into disposable and reusable. Depending on sample type, the market is segregated into monoclonal antibodies, vaccines, cell culture sample, plasma & serum sample, and others. As per application, it is classified into protein & antibody purification, vaccine development, drug discovery, and food & dietary supplement development. The protein & antibody purification segment is further categorized for resins into beads and others. According to end user, the market is categorized into pharmaceutical & biopharmaceutical companies, contract research organizations & contract manufacturing organizations, research & academic institutes, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Findings

By product & service, the product segment dominated the market share in 2023.

Depending on sample type, the monoclonal antibodies segment held a high share of the market.

As per application, the protein & antibody purification segment accounted for the highest market share in 2023.

According to end user, the pharmaceutical & biopharmaceutical companies segment was the highest shareholder in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global hydrophobic interaction chromatography market are Bio-Rad Laboratories, Inc., Sartorius AG, Thermo Fisher Scientific Inc., Tosoh Corporation, Danaher Corporation, Sepax Technologies, Inc., Agilent Technologies, Inc., Merck KGaA, Waters Corporation, and KNAUER Wissenschaftliche Gerate GmbH. These major players have adopted integration, product launch, contract, partnership, and expansion as their key strategies to expand their product portfolio.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hydrophobic interaction chromatography market analysis from 2023 to 2033 to identify the prevailing hydrophobic interaction chromatography market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the hydrophobic interaction chromatography market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global hydrophobic interaction chromatography market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Patient/epidemiology data at country, region, global level
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Product and Service

• Product
  • Type
  • Resin

◦ Type

• Buffer
• Column

◦ Type

• Others
• Service

By Sample type

• Monoclonal antibodies
• Vaccines
• Cell culture sample
• Plasma and serum sample
• Others

By Application

• Protein and antibody purification
  • Resins
  • Beads
  • Others
• Vaccine development
• Drug discovery
• Food and dietary supplement development

By End user

• Research and academic institutes
• Others
• Pharmaceutical and biopharmaceutical companies
• Contract research organizations and contract manufacturing organizations

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa,
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• Sepax Technologies, Inc.
• Tosoh Corporation
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Geno Technology, Inc.
• Waters Corporation
• KNAUER Wissenschaftliche Gerate GmbH
• Bio-Rad Laboratories, Inc.
• Sartorius AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Moderate intensity of rivalry
  • 3.3.2. Moderate bargaining power of buyers
  • 3.3.3. Moderate threat of new entrants
  • 3.3.4. Moderate bargaining power of suppliers
  • 3.3.5. Moderate threat of substitutes
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Increase in R&D expenditure in biopharmaceuticals
    • 3.4.1.2. Rise in demand for biologics and monoclonal antibodies (mAbs)
    • 3.4.1.3. Rise in adoption of biosimilars
  • 3.4.2. Restraints
    • 3.4.2.1. Lack of a skilled workforce
    • 3.4.2.2. High initial investment and operating costs
  • 3.4.3. Opportunities
    • 3.4.3.1. Growth opportunities in emerging markets
    • 3.4.3.2. Technological advancements in hydrophobic interaction chromatography (HIC)

CHAPTER 4: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY PRODUCT AND SERVICE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Product
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. Product Hydrophobic Interaction Chromatography Market by Type
    • 4.2.4.1. Resin Hydrophobic Interaction Chromatography Market by Type
    • 4.2.4.2. Column Hydrophobic Interaction Chromatography Market by Type
    • 4.2.4.2.1. Pre packed Columns Hydrophobic Interaction Chromatography Market by Type
• 4.3. Service
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY SAMPLE TYPE

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Monoclonal antibodies
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Vaccines
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Cell culture sample
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Plasma and serum sample
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country
• 5.6. Others
  • 5.6.1. Key market trends, growth factors and opportunities
  • 5.6.2. Market size and forecast, by region
  • 5.6.3. Market share analysis by country

CHAPTER 6: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY APPLICATION

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Protein and antibody purification
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
  • 6.2.4. Protein and antibody purification Hydrophobic Interaction Chromatography Market by Resins
• 6.3. Vaccine development
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Drug discovery
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country
• 6.5. Food and dietary supplement development
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by region
  • 6.5.3. Market share analysis by country

CHAPTER 7: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY END USER

• 7.1. Overview
  • 7.1.1. Market size and forecast
• 7.2. Pharmaceutical and biopharmaceutical companies
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by region
  • 7.2.3. Market share analysis by country
• 7.3. Contract research organizations and contract manufacturing organizations
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by region
  • 7.3.3. Market share analysis by country
• 7.4. Research and academic institutes
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by region
  • 7.4.3. Market share analysis by country
• 7.5. Others
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by region
  • 7.5.3. Market share analysis by country

CHAPTER 8: HYDROPHOBIC INTERACTION CHROMATOGRAPHY MARKET, BY REGION

• 8.1. Overview
  • 8.1.1. Market size and forecast By Region
• 8.2. North America
  • 8.2.1. Key market trends, growth factors and opportunities
  • 8.2.2. Market size and forecast, by Product and Service
  • 8.2.3. Market size and forecast, by Sample type
  • 8.2.4. Market size and forecast, by Application
  • 8.2.5. Market size and forecast, by End user
  • 8.2.6. Market size and forecast, by country
    • 8.2.6.1. U.S.
    • 8.2.6.1.1. Market size and forecast, by Product and Service
    • 8.2.6.1.2. Market size and forecast, by Sample type
    • 8.2.6.1.3. Market size and forecast, by Application
    • 8.2.6.1.4. Market size and forecast, by End user
    • 8.2.6.2. Canada
    • 8.2.6.2.1. Market size and forecast, by Product and Service
    • 8.2.6.2.2. Market size and forecast, by Sample type
    • 8.2.6.2.3. Market size and forecast, by Application
    • 8.2.6.2.4. Market size and forecast, by End user
    • 8.2.6.3. Mexico
    • 8.2.6.3.1. Market size and forecast, by Product and Service
    • 8.2.6.3.2. Market size and forecast, by Sample type
    • 8.2.6.3.3. Market size and forecast, by Application
    • 8.2.6.3.4. Market size and forecast, by End user
• 8.3. Europe
  • 8.3.1. Key market trends, growth factors and opportunities
  • 8.3.2. Market size and forecast, by Product and Service
  • 8.3.3. Market size and forecast, by Sample type
  • 8.3.4. Market size and forecast, by Application
  • 8.3.5. Market size and forecast, by End user
  • 8.3.6. Market size and forecast, by country
    • 8.3.6.1. Germany
    • 8.3.6.1.1. Market size and forecast, by Product and Service
    • 8.3.6.1.2. Market size and forecast, by Sample type
    • 8.3.6.1.3. Market size and forecast, by Application
    • 8.3.6.1.4. Market size and forecast, by End user
    • 8.3.6.2. France
    • 8.3.6.2.1. Market size and forecast, by Product and Service
    • 8.3.6.2.2. Market size and forecast, by Sample type
    • 8.3.6.2.3. Market size and forecast, by Application
    • 8.3.6.2.4. Market size and forecast, by End user
    • 8.3.6.3. UK
    • 8.3.6.3.1. Market size and forecast, by Product and Service
    • 8.3.6.3.2. Market size and forecast, by Sample type
    • 8.3.6.3.3. Market size and forecast, by Application
    • 8.3.6.3.4. Market size and forecast, by End user
    • 8.3.6.4. Italy
    • 8.3.6.4.1. Market size and forecast, by Product and Service
    • 8.3.6.4.2. Market size and forecast, by Sample type
    • 8.3.6.4.3. Market size and forecast, by Application
    • 8.3.6.4.4. Market size and forecast, by End user
    • 8.3.6.5. Spain
    • 8.3.6.5.1. Market size and forecast, by Product and Service
    • 8.3.6.5.2. Market size and forecast, by Sample type
    • 8.3.6.5.3. Market size and forecast, by Application
    • 8.3.6.5.4. Market size and forecast, by End user
    • 8.3.6.6. Rest of Europe
    • 8.3.6.6.1. Market size and forecast, by Product and Service
    • 8.3.6.6.2. Market size and forecast, by Sample type
    • 8.3.6.6.3. Market size and forecast, by Application
    • 8.3.6.6.4. Market size and forecast, by End user
• 8.4. Asia-Pacific
  • 8.4.1. Key market trends, growth factors and opportunities
  • 8.4.2. Market size and forecast, by Product and Service
  • 8.4.3. Market size and forecast, by Sample type
  • 8.4.4. Market size and forecast, by Application
  • 8.4.5. Market size and forecast, by End user
  • 8.4.6. Market size and forecast, by country
    • 8.4.6.1. Japan
    • 8.4.6.1.1. Market size and forecast, by Product and Service
    • 8.4.6.1.2. Market size and forecast, by Sample type
    • 8.4.6.1.3. Market size and forecast, by Application
    • 8.4.6.1.4. Market size and forecast, by End user
    • 8.4.6.2. China
    • 8.4.6.2.1. Market size and forecast, by Product and Service
    • 8.4.6.2.2. Market size and forecast, by Sample type
    • 8.4.6.2.3. Market size and forecast, by Application
    • 8.4.6.2.4. Market size and forecast, by End user
    • 8.4.6.3. India
    • 8.4.6.3.1. Market size and forecast, by Product and Service
    • 8.4.6.3.2. Market size and forecast, by Sample type
    • 8.4.6.3.3. Market size and forecast, by Application
    • 8.4.6.3.4. Market size and forecast, by End user
    • 8.4.6.4. Australia
    • 8.4.6.4.1. Market size and forecast, by Product and Service
    • 8.4.6.4.2. Market size and forecast, by Sample type
    • 8.4.6.4.3. Market size and forecast, by Application
    • 8.4.6.4.4. Market size and forecast, by End user
    • 8.4.6.5. South Korea
    • 8.4.6.5.1. Market size and forecast, by Product and Service
    • 8.4.6.5.2. Market size and forecast, by Sample type
    • 8.4.6.5.3. Market size and forecast, by Application
    • 8.4.6.5.4. Market size and forecast, by End user
    • 8.4.6.6. Rest of Asia-Pacific
    • 8.4.6.6.1. Market size and forecast, by Product and Service
    • 8.4.6.6.2. Market size and forecast, by Sample type
    • 8.4.6.6.3. Market size and forecast, by Application
    • 8.4.6.6.4. Market size and forecast, by End user
• 8.5. LAMEA
  • 8.5.1. Key market trends, growth factors and opportunities
  • 8.5.2. Market size and forecast, by Product and Service
  • 8.5.3. Market size and forecast, by Sample type
  • 8.5.4. Market size and forecast, by Application
  • 8.5.5. Market size and forecast, by End user
  • 8.5.6. Market size and forecast, by country
    • 8.5.6.1. Brazil
    • 8.5.6.1.1. Market size and forecast, by Product and Service
    • 8.5.6.1.2. Market size and forecast, by Sample type
    • 8.5.6.1.3. Market size and forecast, by Application
    • 8.5.6.1.4. Market size and forecast, by End user
    • 8.5.6.2. South Africa,
    • 8.5.6.2.1. Market size and forecast, by Product and Service
    • 8.5.6.2.2. Market size and forecast, by Sample type
    • 8.5.6.2.3. Market size and forecast, by Application
    • 8.5.6.2.4. Market size and forecast, by End user
    • 8.5.6.3. Saudi Arabia
    • 8.5.6.3.1. Market size and forecast, by Product and Service
    • 8.5.6.3.2. Market size and forecast, by Sample type
    • 8.5.6.3.3. Market size and forecast, by Application
    • 8.5.6.3.4. Market size and forecast, by End user
    • 8.5.6.4. Rest of LAMEA
    • 8.5.6.4.1. Market size and forecast, by Product and Service
    • 8.5.6.4.2. Market size and forecast, by Sample type
    • 8.5.6.4.3. Market size and forecast, by Application
    • 8.5.6.4.4. Market size and forecast, by End user

CHAPTER 9: COMPETITIVE LANDSCAPE

• 9.1. Introduction
• 9.2. Top winning strategies
• 9.3. Product mapping of top 10 player
• 9.4. Competitive dashboard
• 9.5. Competitive heatmap
• 9.6. Top player positioning, 2023

CHAPTER 10: COMPANY PROFILES

• 10.1. Bio-Rad Laboratories, Inc.
  • 10.1.1. Company overview
  • 10.1.2. Key executives
  • 10.1.3. Company snapshot
  • 10.1.4. Operating business segments
  • 10.1.5. Product portfolio
  • 10.1.6. Business performance
• 10.2. Sartorius AG
  • 10.2.1. Company overview
  • 10.2.2. Key executives
  • 10.2.3. Company snapshot
  • 10.2.4. Operating business segments
  • 10.2.5. Product portfolio
  • 10.2.6. Business performance
  • 10.2.7. Key strategic moves and developments
• 10.3. Thermo Fisher Scientific Inc.
  • 10.3.1. Company overview
  • 10.3.2. Key executives
  • 10.3.3. Company snapshot
  • 10.3.4. Operating business segments
  • 10.3.5. Product portfolio
  • 10.3.6. Business performance
  • 10.3.7. Key strategic moves and developments
• 10.4. Tosoh Corporation
  • 10.4.1. Company overview
  • 10.4.2. Key executives
  • 10.4.3. Company snapshot
  • 10.4.4. Operating business segments
  • 10.4.5. Product portfolio
  • 10.4.6. Key strategic moves and developments
• 10.5. Geno Technology, Inc.
  • 10.5.1. Company overview
  • 10.5.2. Key executives
  • 10.5.3. Company snapshot
  • 10.5.4. Operating business segments
  • 10.5.5. Product portfolio
• 10.6. Danaher Corporation
  • 10.6.1. Company overview
  • 10.6.2. Key executives
  • 10.6.3. Company snapshot
  • 10.6.4. Operating business segments
  • 10.6.5. Product portfolio
  • 10.6.6. Business performance
  • 10.6.7. Key strategic moves and developments
• 10.7. Sepax Technologies, Inc.
  • 10.7.1. Company overview
  • 10.7.2. Key executives
  • 10.7.3. Company snapshot
  • 10.7.4. Operating business segments
  • 10.7.5. Product portfolio
• 10.8. Agilent Technologies, Inc.
  • 10.8.1. Company overview
  • 10.8.2. Key executives
  • 10.8.3. Company snapshot
  • 10.8.4. Operating business segments
  • 10.8.5. Product portfolio
  • 10.8.6. Business performance
• 10.9. Merck KGaA
  • 10.9.1. Company overview
  • 10.9.2. Key executives
  • 10.9.3. Company snapshot
  • 10.9.4. Operating business segments
  • 10.9.5. Product portfolio
  • 10.9.6. Business performance
  • 10.9.7. Key strategic moves and developments
• 10.10. Waters Corporation
  • 10.10.1. Company overview
  • 10.10.2. Key executives
  • 10.10.3. Company snapshot
  • 10.10.4. Operating business segments
  • 10.10.5. Product portfolio
  • 10.10.6. Business performance
  • 10.10.7. Key strategic moves and developments
• 10.11. KNAUER Wissenschaftliche Gerate GmbH
  • 10.11.1. Company overview
  • 10.11.2. Key executives
  • 10.11.3. Company snapshot
  • 10.11.4. Operating business segments
  • 10.11.5. Product portfolio

관련자료